A legislation agency representing well being care fraud whistleblowers is suing UnitedHealth Group over its use of a peripheral artery illness take a look at, referred to as QuantaFlo, to extend funds it acquired from the federal government Medicare program, after the Division of Justice declined to pursue a case in opposition to the nation’s largest well being care firm.
The DOJ’s choice was revealed in federal courtroom paperwork unsealed on Friday as the federal government disclosed a $29.75 million settlement of fraud claims with Semler Scientific, the maker of the QuantaFlo take a look at. The Justice Division additionally reached a $7.2 million settlement with CR Bard, the previous distributor of the take a look at now owned by BD, based on the paperwork unsealed within the Center District Court docket of Florida.
“Medical machine corporations that misrepresent the capabilities of their merchandise and encourage suppliers to invoice Medicare for companies that don’t meet protection necessities drain vital taxpayer-funded sources,” stated Isaac Bledsoe, performing particular agent answerable for the Well being and Human Providers Division Workplace of Inspector Common, in a assertion.
This text is unique to STAT+ subscribers
Unlock this text — plus each day market-moving biopharma evaluation — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.